ORKA FY 2024 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ORKAOruka Therapeutics, Inc.

$1B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$27,000

Operating Income

-$88M

Net Income

-$84M

EPS (Diluted)

$-4.99

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$58M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$396M

Total Liabilities

$14M

Stockholders' Equity

$382M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$27,000	-$111,000	+75.7%
Operating Income	-$88M	-$7M	-1107.8%
Net Income	-$84M	-$5M	-1468.2%